CORZ
Director buying? That’ll get investors’ attention
Core Scientific says one of its directors bought 7,000 shares for a total of $134,330. That’s not billionaire-whale money, but it is real skin in the game — and markets tend to notice when insiders are reaching for the buy button instead of heading for the exit.
Why you should care
Insider purchases can matter because the person doing the buying usually knows the company’s business better than most outsiders. Sometimes it’s just a portfolio move. Sometimes it’s a quiet vote of confidence that the stock is undervalued or the worst is behind it.
For Core Scientific, a buy like this adds to the “maybe management likes what they see” narrative. Investors often treat these trades as a small but useful clue, not a full thesis. Think of it like seeing the chef eat their own food — not proof the restaurant is Michelin-starred, but definitely not nothing.
The fine print
- The transaction was valued at $134,330.
- Insider buys can be bullish signals, but they’re not a guarantee.
- The real question for investors is whether the company can turn confidence into actual operating progress.
Big picture: when insiders buy, they’re putting a little more than words on the table — and Wall Street tends to keep score.